{"title":"Seven-Year Follow-Up of Screening for Hypertension and Diabetes at a Dental Clinic","authors":"G. Friman","doi":"10.37191/mapsci-2582-3736-1(2)-011","DOIUrl":null,"url":null,"abstract":"Objective: To describe the distribution of risk, diagnosis and pharmacological treatments for diabetes and hypertension after seven years among patients provided with opportunistic medical screening in a dental setting.\n\nMaterial and Methods: The initial screening’s 170 participants were asked to take part in a seven-year follow-up study. Data were collected through self-reported information in a written health declaration. Outcome measures: \n\n• Number of study participants who had passed away \n\n• Prescription of antidiabetics or antihypertensives\n\n• Changes in weight and height to calculate body mass index (BMI)\n\nResults: The follow-up study consisted of 151 participants. Twenty had passed away. The risk needs for medicating with antihypertensive drugs after seven years for those not receiving pharmacological treatment at the initial screening was 3.7 times greater (p=0.025 CI 1.2-11.3) for participants with a diastolic blood pressure (BP) ≥ 90 mm Hg (85 for diabetics) than for the others. The risk was 3.9 times greater (p=0.020 CI 1.2-12.6) for those with a systolic BP of 140-159 mm Hg and 54.2 times greater (p<0.0001 CI 9.8-300.3) for those with a systolic BP ≥ 160 mm Hg than for those with a systolic BP 140 mm Hg. There were no changes in BMI.\n\nConclusion: At least one in ten cases of incorrect medication or undiagnosed hypertension may be identifiable through opportunistic medical screening","PeriodicalId":92922,"journal":{"name":"Journal of dentistry and oral sciences","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of dentistry and oral sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37191/mapsci-2582-3736-1(2)-011","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
Objective: To describe the distribution of risk, diagnosis and pharmacological treatments for diabetes and hypertension after seven years among patients provided with opportunistic medical screening in a dental setting.
Material and Methods: The initial screening’s 170 participants were asked to take part in a seven-year follow-up study. Data were collected through self-reported information in a written health declaration. Outcome measures:
• Number of study participants who had passed away
• Prescription of antidiabetics or antihypertensives
• Changes in weight and height to calculate body mass index (BMI)
Results: The follow-up study consisted of 151 participants. Twenty had passed away. The risk needs for medicating with antihypertensive drugs after seven years for those not receiving pharmacological treatment at the initial screening was 3.7 times greater (p=0.025 CI 1.2-11.3) for participants with a diastolic blood pressure (BP) ≥ 90 mm Hg (85 for diabetics) than for the others. The risk was 3.9 times greater (p=0.020 CI 1.2-12.6) for those with a systolic BP of 140-159 mm Hg and 54.2 times greater (p<0.0001 CI 9.8-300.3) for those with a systolic BP ≥ 160 mm Hg than for those with a systolic BP 140 mm Hg. There were no changes in BMI.
Conclusion: At least one in ten cases of incorrect medication or undiagnosed hypertension may be identifiable through opportunistic medical screening
目的:描述在牙科机构提供机会性医学筛查的患者7年后糖尿病和高血压的风险分布、诊断和药物治疗。材料和方法:最初筛选的170名参与者被要求参加一项为期7年的随访研究。数据是通过书面健康声明中自我报告的信息收集的。结果测量:•研究参与者的死亡人数•抗糖尿病或抗高血压药物的处方•体重和身高的变化计算体重指数(BMI)结果:随访研究包括151名参与者。20人去世了。对于舒张压(BP)≥90 mm Hg(糖尿病患者为85)的参与者,7年后未接受药物治疗的抗高血压药物风险需求是其他参与者的3.7倍(p=0.025 CI 1.2-11.3)。收缩压为140-159 mm Hg的患者的风险是收缩压为140 mm Hg的患者的3.9倍(p=0.020 CI 1.2-12.6),收缩压≥160 mm Hg的患者的风险是收缩压为140 mm Hg的患者的54.2倍(p<0.0001 CI 9.8-300.3)。BMI没有变化。结论:至少十分之一的不正确用药或未确诊的高血压病例可通过机会性医学筛查发现